Consonance Capital Management LP Keros Therapeutics, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$29.27 - $43.71 $26 Million - $38.8 Million
-887,885 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$42.4 - $70.11 $98,537 - $162,935
-2,324 Reduced 0.26%
887,885 $37.7 Million
Q1 2021

May 17, 2021
BUY
$54.0 - $75.28 $18 Million - $25.1 Million
333,114 Added 59.79%
890,209 $54.8 Million
Q4 2020

Feb 16, 2021
BUY
$36.0 - $82.74 $20.1 Million - $46.1 Million
557,095 New
557,095 $39.3 Million

Others Institutions Holding KROS

# of Institutions
174
Shares Held
30.3M
Call Options Held
76.8K
Put Options Held
9K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $441M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email